Skip to main content
. 2021 Feb 3;43:e2021011. doi: 10.4178/epih.e2021011

Table 2.

Meta-analysis results for the association between the presence of gallstones and the risk of BTC by subgroups

Subgroup No. of studies OR (95% CI)1 I2 value (%) p for heterogeneity
All studies 26 4.38 (3.23, 5.93) 91.2 <0.001
Study design
 Cohort study 7 3.17 (2.28, 4.39) 79.0 <0.001
 Case-control study 19 5.04 (3.36, 7.56) 90.5 <0.001
Sex
 Male 9 3.40 (2.70, 4.28) 35.8 0.132
 Female 9 4.26 (2.75, 6.59) 84.5 <0.001
Geographic area
 Asia 15 5.25 (3.50, 7.86) 82.4 <0.001
 Non-Asia2 11 3.58 (2.17, 5.91) 95.1 <0.001
Study period3
 Before 2000 8 5.39 (2.57, 11.34) 95.5 <0.001
 Around 2000 7 2.67 (2.10, 3.39) 38.6 0.135
 After 2000 7 5.21 (2.13, 12.74) 85.7 <0.001
 No records 4 5.73 (2.61, 12.61) 87.3 <0.001
Measurement of gallstones
 Medical records with imaging studies 8 7.09 (3.87, 12.98) 64.5 0.004
 Medical records without imaging studies 16 3.81 (2.48, 5.85) 93.9 <0.001
 No records 2 3.47 (2.88, 4.18) 17.1 0.272
Study quality4
 High NOS 14 3.99 (2.85, 5.59) 75.6 <0.001
 Low NOS 12 4.81 (2.87, 8.05) 94.9 <0.001
Adjustment for age, yes 21 3.71 (2.66, 5.16) 90.6 <0.001
Adjustment for sex, yes 20 3.92 (2.77, 5.55) 91.2 <0.001
Adjustment for comorbidities, yes 7 3.05 (1.84, 5.05) 75.7 <0.001
Adjustment for lifestyle factors, yes5 7 4.84 (1.95, 11.98) 85.5 <0.001
Adjustment for education, yes 1 9.42 (3.56, 24.91) - -
Adjustment for geographic areas, yes 4 7.34 (2.28, 23.62) 87.6 0.000

BTC, biliary tract cancer; OR, odds ratio; CI, confidence interval; NOS, Newcastle-Ottawa scale.

1

OR refers to a summary estimate of effects based on a random-effects model.

2

Non-Asia including USA and European areas.

3

Study period was defined by the study’s starting point (a) and ending point (b). Before 2000, (a) and (b) are both before 2000; around 2000, (a) is before 2000 but (b) is after 2000; after 2000, (a) and (b) are both after 2000.

4

Quality scores greater than or equal to the median value were judged as a high NOS (≥7).

5

Adjustment for lifestyle factors such as alcohol, smoking, body mass index, etc.